Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1697 |
|---|---|
| Identifier | NCT04655807 |
| Trial Title | A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: JNJ-64304500|DRUG: Placebo|DRUG: Adalimumab|DRUG: Ustekinumab |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | Evansville |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2021-03-03 |
|---|---|
| Primary Completion Date | 2023-05-24 |
| Completion Date | 2023-09-04 |